Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
Microcaps logo — Breakthrough technology to naturally encapsulate ingredients...

Microcaps

Breakthrough technology to naturally encapsulate ingredients and fragrances into visually appealing alginate-beads.

Founded 2019 Switzerland Schlieren, Switzerland 35 employees Series A Total: $14.43M Biotechnology, IT +1

General Information

Company Name Microcaps
Founded Year 2019
Location Switzerland Schlieren, Switzerland
Employees 35
Industries Biotechnology, IT, Information Technology
Funding Stage Series A
Business Model B2B, D2C, B2B2C
Revenue Model Licensing, Product Sales, Service Fee
Social

BounceWatch is an independent company data service, not affiliated with Microcaps. To contact Microcaps, visit microcaps.ch.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Microcaps compare?

A PDF of Microcaps and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Microcaps soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Microcaps

Microcaps, founded in 2019, is pioneering a Breakthrough technology that naturally encapsulates ingredients and fragrances. Their technology promises enhanced protection and a distinctive visual and sensory experience, catering primarily to the fine fragrance, cosmetics, nutrition, and pharma sectors.

Operating out of Switzerland, this innovative biotechnology firm leverages its patented solution to offer companies improved performance, new product claims, enhanced shelf appeal, and increased revenue potential. The encapsulation process harnesses alginate-beads to deliver visually appealing products while ensuring ingredient integrity.

In its latest funding round, the company secured a Fr.9.30M Series A investment on 05 June 2024. Key investors included Helvetica Capital AG, ETH Zurich Foundation, and Zürcher Kantonal Bank. These strategic partnerships reinforce Microcaps’ promising position in the Biotechnology and Information Technology industries.

Business keywords: encapsulation technology, microcapsules, alginate beads, fragrance encapsulation, cosmetics innovation, nutrition encapsulation, pharmaceutical microcapsules, microfluidics, scalable production, automated encapsulation, size control technology, sensory experience enhancement, fine fragrance industry, product stability enhancement, visual appeal in products

Services & Products

Fragrance Encapsulation Technology
Microencapsulation of Fragrances
Water-Based Perfume Development
Production of Ethanol-Free Fragrances

Target Customers

Luxury Fragrance Brands Cosmetics Companies Skincare Brands Consumer Beauty Products Manufacturers

Funding Rounds & Investors (6)

View All
Funding Stage Amount Investors Lead Investors Date
Series A Fr.9.30M 3
Helvetica Capital AG ETH Zurich Foundation
Helvetica Capital AG, ETH Zurich Foundation +1
05 Jun 2024
Seed Round Fr.5.00M 4
Helvetica Capital AG Lichtsteiner Foundation ETH Zurich Foundation
Helvetica Capital AG, Lichtsteiner Foundation +2
26 Jan 2021
Pre Seed Round Fr.100.00K 1
Venture Kick
Venture Kick
17 Jul 2019
Non Equity Assistance Undisclosed 1
MassChallenge
MassChallenge
15 May 2019
Grant Fr.20.00K 1
Venture Kick
Venture Kick
21 Nov 2018
Grant Fr.10.00K 1
Venture Kick
Venture Kick
26 Jun 2018

Microcaps Alternatives & Competitors

Microcaps vs
Digi.Bio
Digi.Bio The Netherlands

Single cell, AI-driven, lab-on-a-chip technology to accelerate the development of breakthrough thera...

Convertible Note
6 employees
AI, Biotechnology
Compare Microcaps vs Digi.Bio
Microcaps vs
Autonomous Medical Devices Incorporated
Autonomous Medical Devices Incorporated United States

A medical diagnostics company dedicated to developing and manufacturing point-of-care diagnostic dev...

Grant
54 employees
Biotechnology, Health Care
Compare Microcaps vs Autonomous Medical Devices Incorporated

FAQ About Microcaps

Breakthrough technology to naturally encapsulate ingredients and fragrances into visually appealing alginate-beads.
Microcaps was founded in 2019.
Microcaps is headquartered in Schlieren, Switzerland.
Microcaps operates in Biotechnology, IT and Information Technology. Its work centres on encapsulation technology, microcapsules, alginate beads and fragrance encapsulation. Its customers include Luxury Fragrance Brands, Cosmetics Companies and Skincare Brands.
Microcaps has a B2B, D2C and B2B2C business model. Its revenue comes from Licensing, Product Sales and Service Fee.
Microcaps has approximately 35 employees.
Microcaps has completed 6 funding rounds, raising a total of $14.43M. The latest funding stage is Series A.
Microcaps offers: Fragrance Encapsulation Technology, Microencapsulation of Fragrances, Water-Based Perfume Development, Production of Ethanol-Free Fragrances.
Top alternatives and competitors to Microcaps include Digi.Bio, Autonomous Medical Devices Incorporated. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Microcaps and Digi.Bio are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Microcaps, https://bouncewatch.com/company/microcaps-ag, updated 2 April 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout